Pionyr Immunotherapeutics' Incubator/Accelerator Round

Pionyr Immunotherapeutics raised a round of funding on February 01, 2015. Investors include JLabs.

Pionyr, formerly Precision Immune, is developing cancer immunotherapies that target the tumor microenvironment to enhance the body's antitumor immunity. The company is exploiting target discovery and …

Articles about Pionyr Immunotherapeutics' Incubator/Accelerator Round: